1. T. Ishizaka, K. Ishizaka and H. Tomioka, Release of histamine and slow reacting
substance of anaphylaxis (SRS-A) by IgE-anti-IgE reactions on monkey mast cells,
J. Immunol., 108, 513-520 (1972).
2. K. F. Austen, Biologic implications of structural and functional characteristics of
the chemical mediators of immediate type hypersensitivity, Harvey Lect., 73,
93-161 (1979).
3. G. K. Adams and L. M. Lichtenstein, In vitro studies of antigen-induced
bronchospasm: effect of antihistamine and SRS-A antagonist on response to
sensitized guinea pig and human airways to antigen, J. Immunol., 122, 555-562
(1979).
4. L. B. Schwartz and K. F. Austen, Structural and function of the chemical mediators
of mast cells, Prog. Allergy, 34, 271-321 (1984).
5. A. G. Semb, J. Vage and O. D. Mjos, Oxygen free radical producing leukocytes cause functional depression of isolated rat hearts: role of leukotrienes, J. Mol. Cell. Cardiol., 22, 555-563 (1990).
6. D. Harman and L. H. Piette, Free radical theory of aging: free radical reactions in serum, J. Gerontol., 21,560-565 (1966).
7. D. A. Parks and D. N. Granger, Ischemia-induced vascular changes: role of xanthine oxidase and hydroxyl radicals, Am. J. Physiol., 245, G285-G289 (1983).
8. J. M. McCord, Oxygen-derived free radicals in postischemic tissue injury, N. Engl. J. Med., 312, 159-163 (1985).
9. P. R. Kvietys, S. M. Smith, M. B. Grisham and E. A. Manaci, 5-Aminosalicylic acid protects against ischemia/reperfusion-induced gastric bleeding in the rat, Gastroenterology, 94, 733-738 (1988).
10. J. M. McCord, Free radicals and inflammation: protection of synovial fluid by
superoxide dismutase, Science, 185, 529-531 (1974).
11. R. E. Allen, D. R. Blake, N. B. Nazhat and P. Jones, Superoxide radical
generation by inflamed human synovium after hypoxia, Lancet, 2, 282-283
(1989).
12. P. A. Craven, J. Pfanstiel, R. Saito and F. R. DeRubertis, Action of sulfasalazine
and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile
acid-induced increases in colonic epithelial cell loss and proliferative activity,
Gastroenterology, 92, 1998-2008 (1987).
13. M. B. Grisham and D. N. Granger, Neutrophil-mediated mucosal injury: Role of
reactive oxygen metabolites, Dig. Dis. Sci., 33 (3 Suppl), 6S-15S (1988).
14. G. Weissmann, J. E. Smolen and H. M. Korchak, Release of inflammatory
mediators from stimulated neutrophils, N. Engl. J. Med., 303, 27-34 (1980).
15. M. Davies, A. J. Barrett, J. Travis, E. Sanders and G. A. Coles, The degradation
of human glomerular basement membrane with purified lysosomal proteinases:
evidence for the pathogenetic role of the polymorphonuclear leukocyte in glomerulonephritis, Clin. Sci. Mol. Med., 54, 233-240 (1978).
16. H. Menninger, R. Putzier, W. Mohr, D. Weissinghage and K. Tillmann,
Granulocyte elastase at the site of cartilage erosion by rheumatoid synovial tissue,
J. Rheumatol., 39, 145-156 (1980).
17. J. Saklatvala and A. J. Barrett, Identification of proteinases in rheumatoid
synovium: detection of leukocyte elastase, cathepsin G and another serine
proteinase, Biochem. Biophys. Acta., 615, 167-177 (1980).
18. J. M. Gutteridge and B. Halliwell, The measurement and mechanism of lipid
peroxidation in biological system, Trends. Biochem. Sci., 15, 129-135 (1990).
19. W. Solbach, H. Moll and M. Rollinghoff, Lymphocytes play the music but the
macrophages cells the tune, Immunol. Today, 12, 4-6 (1991).
20. S. L. Kunkel, S. W. Chensue and S. H. Phan, Prostaglandins as endogenous
mediators of interleukin 1 production, J. Immunol., 136, 186-192 (1986).
21. B. Beutler and A. Cerami, Tumor necrosis factor, cachexia, shock, and
inflammation :a common mediator, Ann. Rev. Biochem., 57, 505-518 (1988).
22. A. H. Ding, C. F. Nathan and D. J. Stuehr, Release of reactive nitrogen
intermediates and reactive oxygen intermediates from mouse peritonel
macrophages: comparison of activiting cytokines and evidence for independent
production, J. Immunol., 141, 2407-2412 (1988).
23. C. Thiermermann and J. R. Vane, Inhibition of nitric oxide synthesis reduces the
hypotension induced by bacterial lipopolysaccharides in the rat in vivo, Eur. J.
Pharmacol., 182, 591-595 (1990).
24. B. Beutler and A. Cerami, Tumor necrosis factor, cachexia, shock, and
inflammation :a common mediator, Ann. Rev. Biochem., 57, 505-518 (1988).
25. K. J. Tracey, Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F.
Lowry and A. Cerami, Anti-cachectin/TNF monoclonal antibodies prevent septic
sock during lethal bacteraemia, Nature, 330, 662-664 (1987).
26. M. Mallat and B. Chamak, Brain macrophages: neurotoxic or neurotrophic
effector cells, J. Leukoc. Biol., 56, 416-422 (1994).
27. J. Gehrmann, Y. Matsumoto and G. W. Kreutzberg, Microglia: intrinsic
immunoeffector cell of the brain, Brain Res. Rev., 20, 269-28 (1995).
28. F. M. Hofman, D. R. Hinton, K. Johnson and J. E. Merrill, Tumor necrosis factor
identified in multiple sclerosis brain, J. Exp. Med., 170, 607-612 (1989).
29. J. Rogers, J. Luber-Narod, S. D. Styren and W. H. Civin, Expression of immune
system-associated antigens by cells of the human central nervous system:
relationship to the pathology of Alzheimer's disease, Neurobiol. Aging, 9,
339-349 (1988).
30. P. L. McGeer, S. Itagaki, B. E. Boyes and E. G. McGeer, Reactive microglia are
positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's
disease brains, Neurology, 38, 1285-1291 (1988).
31. D. W. Dickson, L. A. Mattiace, K. Kure, K. Hutchins, W. D. Lyman and C. F.
Brosnan, Microglia in human disease, with an emphasis on acquired immune
deficiency syndrome, Lab. Invest., 64, 135-156 (1991).
32. P. J. Gebicke-Haerter, J. Bauer, A. Schobert and H. Northoff,
Lipopolysaccharide free conditions in primary astrocyte cultures allow growth
and isolation of microglia cells, J. Neurosci., 9, 183-194 (1989).
33. L. Minghetti, A. Nicolini, E. Polazzi, C. Crfiinon, J. Maclouf and G. Levi,
Inducible nitric oxide synthase expression in activated rat microglial cultures is
down-regulated by exogenous prostaglandin E2 and by cyclooxygenase
inhibitors, Glia, 19, 152-160 (1997).
34. C. C. Chao, S. Hu, T. W. Molitor, E. G. Shaskanand P. K. Peterson, Activated
microglia mediate neuronal cell death injury via a nitric oxide mechanism, J.
Immunol., 149, 2736-2741 (1992).
35. J. E. Merrill, L. J. Ignarro, M. P. Sherman, J. Melinek and T. E. Lane, Microglial
cell cytotoxicity of oligodendrocytes is mediated through'nitric oxide, J.
Immunol., 151, 2132-2141 (1993).
36. L. Meda, M. A. Cassatella, G. I. Szendrei, L. Jr. Otvos, P. Baron, M. Villalba, D.
Ferrari and F. Rossi, Activation of microglial cells by β-amyloid protein and
interferon-γ, Nature, 374, 647-650 (1995).
37. M. Bamford, G. Walkinshaw, R. Brown,Therapeutic applications of apoptosis
research. Experimental Cell Research 256, 1-11 (2000).
38. O. F. Jens, Cancer cell cycle control. Anticancer Res. 19: 4772-4780, (1999).
39. H.N.Crans, K.M.Sakamoto. Transcription factors and translocations in lymphoid
and myeloid leukemia. Leukemia 15, 313-331(2001).
40. R. M. Stone; R. J. Mayer, Treatment of the newly diagnosed adult with de novo
acute myeloid leukemia. Hematol. Oncol. Clin. N. Am. 7(1): 47-64, (1993).
41. D. F. Hoelzer, Therapy of the newly diagnosed adult with acute lymphoblastic
leukemia. Hematol. Oncol. Clin. N. Am. 7(1): 139-160, (1993).
42. H. M. Kantarjian; T. L. Smith; S. O'Brien; M. Beran; S. Pierce; M. Talpaz,
Prolonged survival in chronic myelogenous leukemia after cytogenetic response
to interferon-alpha therapy. An. Intern. Med. 122(4): 254-261, (1995).
43. G. B. Faguet, Chronic lymphocytic leukemia: an updated review.I: Clin. Oncol.
12(9): 1974-1990, (1994).
44. G. Lopez-Lluch; M. I. Huron; F. J. Alcain; J. M. Quesada; P. Navas, Redox
regulation of camp levels by ascorbate in 1,25-dihydroxy-vitamine d3-induced
differentication of HL-60 cells. Biochem. J., 331(Pt. 1), 21-27(1998).
45. Q. He; D. Jiang, A novel aminosteroid is active for proliferation inhibition and differentiation induction of human acute myeloid leukemia HL-60 cells. Leuk. Res. 23(4), 369-372 (1999).
46. M. V . Berridge; A. S. Tan, Characterization of the cellular reduction of
3-( 4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide (MTT):
subcellular localization, substrate dependence, and involvement of
mitochondrial electron transport in MTT reduction. Arch. Biochem. Biophys.
303, 474-482 (1993).
47. M. Markert, P. C. Andrews, B. M. Babior, Measurement of 02- production by
human neutrophils. The preparation and assay of NADPH oxidase-containing
particles from human neutrophils, Methods Enzymol., 105, 358-365 (1984).
48. A. C. Newby, Role of adenosine deaminase, ecto-(5'-nucleo-tidase) and
ecto-(non-specific phosphatase) in cyanide-induced adenosine monophosphate
catabolism in rat polymorphonuclear leucocytes, Biochem. J., 186, 907-918
(1980).
49. A. J. Barrett, "A Laboratory Handbook", Dingle, J. T. ed.
(Elsevier/North-Holland, Amsterdam), 118-120 (1972).
50. D. R. Absolom, Basic methods for the study of phagocytosis, Methods
Enzymol., 132, 95-179 (1986).
51. J. P Wang, S. L. Raung, M. F. Hsu and C. C. Lin, Inhibition by gomisin C (a
lignan from Schizandra chinensis) of the respiratory burst of rat neutrophils, Br.
J. Pharmacol., 113, 945-953 (1994).
52. B. Goldberg and A. Stem, The role of the superoxide anion as a toxic species in
the erythrocyte, Arch. Biochem. Biophys., 178, 218-225 (1977).
53. D. E. McClain, M. A. Donlon, S. Chock and G. N. Catravas, The effect of
calmodulin on histamine release in the rat peritoneal mast cell, Biochem.
Biophys. Acta., 763, 419 (1983).
54. T. H. P. Hanahae, Mechanism of histamine release from rat isolated peritoneal
mast cells by dextran: the role ofimmunglobulin E., Agents Action, 14, 468
(1984).
55. A. R. Johnson and E. G. Erdos, Release of histamine from mast cell by
vasoactive peptides, Proc. Soc. Exp. Biol. Med., 142, 1252-1256 (1973).
56. R. Hakanson and A. L. Ronnberg, Improved fluorometric assay of histamine,
Antlyt. Biochem., 60, 560-567 (1974).
57. S. B. Corradin, J. Manuel, S. D. Donini, E. Quattrocchi and P.
Ricciardi-Castagnoi, Inducible nitric oxide synthase activity of cloned murine
microglial cells, Glia 7, 255-262 (1993).
58. L. Minghetti, A. Nicolini, E. Polazzi, C. Creminon, J. Maclouf and G. Levi,
Inducible nitric oxide synthase expression in activated rat microglial culcures is
down-regulated by exogenous prostaglandin E2 and by cyclooxygenase
inhibitors, Glia 19, 152-160 (1997).
59. 張瓊云，6, 7, 4΄-取代異黃烷苯醌及其相關化合物之合成與生理活性，中國醫藥學院藥物化學研究所博士論文，2001。